Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For LXS.SW
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 0.24 2.48 2.48
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 408.12 28.26 5.56
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.20 52.75 52.13
Cash -21.98 4.48 5.74
Capex 70.45 -0.45 -1.53
Free Cash Flow 8.89 -1.13 1.04
Revenue 11.91 18.61 16.63
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 7.85 0.17 0.16
Operating Margin 40.93 -0.02 -0.04
ROA 86.18 -0.01 -0.07
ROE 87.14 -0.02 -0.17
ROIC 47.09 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of LXS.SW is permitted for members.
5 Growth
The "Growth Entry" for the Focus of LXS.SW is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of LXS.SW is permitted for members.